Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states

Current Opinion in Hematology

Volumn 7, Issue 1, 2000, Pages 64-69

  Urieli Shoval, Simcha ^a   Linke, Reinhold P ^b   Matzner, Yaacov ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; SERUM AMYLOID A;

AMYLOIDOSIS; ATHEROSCLEROSIS; CELL ADHESION; CELL AGGREGATION; CELL MIGRATION; CELL PROLIFERATION; HUMAN; INFLAMMATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; THROMBOSIS;

ACUTE-PHASE PROTEINS; APOLIPOPROTEINS; HUMANS; PROTEIN PRECURSORS; SERUM AMYLOID A PROTEIN;

EID: 0033988643     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200001000-00012     Document Type: Review

References (71)

1. 1 Benditt EP, Lagunoff D, Eriksen N, Iseri OA: Amyloid: extraction and preliminary characterization of some proteins. Arch Pathol 1962, 74:323-330.
2. 2 Benditt EP, Eriksen N: Amyloid III: a protein related to the subunit structure of human amyloid fibrils. Proc Natl Acad Sci U S A 1966, 55:308-316.
3. 3 Levin M, Pras M, Franklin EC: Immunologic studies of the major nonimmunoglobulin protein of amyloid: identification and partial characterization of a related serum component. J Exp Med 1973, 132:373-380.
4. 4 Linke RP, Sipe JD, Pollock PS, Ignaczak TF, Glenner GG: Isolation of a low molecular weight serum component antigenically related to an amyloid fibril protein of unknown origin. Proc Natl Acad Sci U S A 1975, 72:1473-1476.
5. 5 Eriksen N, Meek RL, Benditt EP: The SAA lipoprotein family. In Acute Phase Proteins: Molecular Biology, Biochemistry and Clinical Applications. Edited by Mackiewicz A, Kushner I, Boumann H. Boca Raton: CRC Press; 1993:93-106.
6. 6 Betts JC, Edbrooke MR, Thakker R, Woo P: The human acute-phase serum amyloid A gene family: structure, evolution and expression in hepatoma cells. Scand J Immunol 1991, 34:471-482.
7. 7 Uhlar CM, Burgess CJ, Sharp PM, Whitehead AS: Evolution of the serum amyloid A (SAA) protein superfamily. Genomics 1994, 19:228-235.
8. 8 Sellar GC, Jordan SA, Bickmore WA, Fantes JA, van Heyningen V, Whitehead AS: The human serum amyloid A protein (SAA) superfamily gene cluster: mapping to chromosome 11p15.1 by physical and genetic linkage analysis. Genomics 1994, 19:221-227.
9. 9 Watson G, See CG, Woo P: Use of somatic cell hybrids and fluorescence in situ hybridization to localize the functional serum amyloid A (SAA) genes to chromosome 11p15.4-p15.1 and the entire SAA superfamily to chromosome 11p15. Genomics 1994, 23:694-696.
10. 10 Kluve-Beckerman B, Drumm ML, Benson MD: Nonexpression of the human serum amyloid A three (SAA3) gene. DNA Cell Biol 1991, 10:651-661.
11. 11 Whitehead AS, deBeer MC, Steel DM, Rits M, Lelias JM, Lane WS, deBeer FC: Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J Biol Chem 1992, 267:3862-3867.
12. 12 Urieli-Shoval S, Meek RL, Hanson RH, Eriksen N, Benditt EP: Human serum amyloid A genes are expressed in monocyte/macrophage cell lines. Am J Pathol 1994, 145:650-660.
13. 13 Meek RL, Urieli-Shoval S, Benditt EP: Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function. Proc Natl Acad Sci U S A 1994, 91:3186-3190.
14. 14 Urieli-Shoval S, Cohen P, Eisenberg S, Matzner Y: Widespread expression of serum amyloid A in histologically normal human tissues: predominant localization to the epithelium. J Histochem Cytochem 1998, 46:1377-1384. By in situ hybridization, immunohistochemistry, and reverse transcriptase polymerase chain reaction analyses, the authors demonstrated SAA mRNA and protein expression in many histologically normal human tissues. The authors suggested that one or more SAA proteins produced in human tissues might be constitutively expressed to serve as a first line of defense or in proper maintenance and function of human tissues (housekeeping role). Furthermore, the various proposed functions of SAA might be exerted by SAA locally produced in human tissues rather than by liver-derived SAA.
15. 15 Butler A, Whitehead AS: Mapping of the mouse serum amyloid A gene cluster by long-range polymerase chain reaction. Immunogenetics 1996, 44:468-474.
16. 16 Meek RL, Benditt EP: Amyloid A gene family expression in different mouse tissues. J Exp Med 1986, 164:2006-2017.
17. 17 Sipe J: Revised nomenclature for serum amyloid A (SAA). Amyloid:Int J Exp Clin Invest 1999, 6:67-70. This is a revised nomenclature for the multiple SAA genes in humans and mice and their various allelic variants. The attendees of the recent SAA Gordon Research Conference and the VIII International Symposium on Amyloidosis recommended it. The attention of AA and SAA researchers is called to the changes in the SAA nomenclature.
18. 18 Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999, 340:448-454.
19. 19 Meek RL, Eriksen N, Benditt EP: Serum amyloid A in the mouse: sites of uptake and mRNA expression. Am J Pathol 1989, 135:411-419.
20. 20 Ramadori G, Sipe JD, Colten HR: Expression and regulation of the murine serum amyloid A (SAA) gene in extrahepatic sites. J Immunol 1985, 135:3645-3647.
21. 21 Hardardottir I, Sipe J, Moser AH, Fielding CJ, Feingold KR, Grunfeld C: LPS and cytokines regulate extrahepatic mRNA levels of apolipoproteins during the acute phase response in Syrian hamsters. Biochim Biophys Acta 1997, 1344:210-220.
22. 22 Yamada T, Kakihara T, Kamishima T, Fukuda T, Kawai T: Both acute phase and constitutive serum amyloid A are present in atherosclerotic lesions. Pathol Int 1996 46:797-800.
23. 23 Kumon Y, Sipe JD, Brinckerhoff CE, Schreiber BM: Regulation of extrahepatic apolipoprotein serum amyloid A (apoSAA) gene expression by interleukin-1 alpha alone: synthesis and secretion of apoSAA by cultured aortic smooth muscle cells. Scand J Immunol 1997, 46:284-291.
24. 24 Steel DM, Donoghue FC, O'Neill RM, Uhlar CM, Whitehead AS: Expression and regulation of constitutive and acute phase serum amyloid A mRNAs in hepatic and non-hepatic cell lines. Scand J Immunol 1996, 44:493-500.
25. 25 Liang JS, Sloane JA, Wells JM, Abraham CR, Fine RE, Sipe JD: Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain. Neurosci Lett 1997, 225:73-76.
26. 26 Kumon Y, Suehiro T, Hashimoto K, Nakatani K, Sipe JD: Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells. J Rheumatol 1999, 26:785-790.
27. 27 Jensen LE, Whitehead AS: Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J 1998, 334:489-503. This is an extensive review of the various molecular mechanisms regulating SAA expression. It includes proposed models for the cytokine network, transcription activators, and repressors mediating expression of SAA during the acute-phase response.
28. 28 Ray BK, Chatterjee S, Ray A: Mechanism of minimally modified LDL-mediated induction of serum amyloid A gene in monocyte/macrophage cells. DNA Cell Biol 1999, 18:65-73.
29. 29 Ray A, Schatten H, Ray BK: Activation of Sp1 and its functional co-operation with serum amyloid A-activating sequence binding factor in synoviocyte cells trigger synergistic action of interleukin-1 and interleukin-6 in serum amyloid A gene expression. J Biol Chem 1999, 274:4300-4308.
30. 30 Jiang SL, Samols D, Rzewnicki D, Macintyre SS, Greber I, Sipe J, Kushner I: Kinetic modeling and mathematical analysis indicate that acute phase gene expression in Hep3B cells is regulated by both transcriptional and posttranscriptional mechanisms. J Clin Invest 1995, 95:1253-1261.
31. 31 Jiang SL, Lozanski G, Samols D, Kushner I: Induction of human serum amyloid A in Hep3B cells by IL-6 and IL-1 beta involves both transcriptional and post-transcriptional mechanisms. J Immunol 1995, 154:825-831.
32. 32 Lozanski G, Berthier F, Kushner I: The sphingomyelin-ceramide pathway participates in cytokine regulation of C-reactive protein and serum amyloid A, but not alpha-fibrinogen. Biochem J 1997, 328:271-275.
33. 33 Badolato R, Johnston JA, Wang JM, McVicar D, Xu LL, Oppenheim JJ, Kelvin DJ: Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J Immunol 1995, 155:4004-4010.
34. 34 Olsson N, Siegbahn A, Nilsson G: Serum amyloid A induces chemotaxis of human mast cells by activating a pertussis toxin-sensitive signal transduction pathway. Biochem Biophys Res Commun 1999, 254:143-146.
35. 35 Su SB, Gong W, Gao JL, Shen W, Murphy PM, Oppenheim JJ, Wang JM: A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med 1999, 189:395-402.
36. 36 Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL, et al.: Serum amyloid A is a chemoattractant: induction of migration, adhesion and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 1994, 180:203-209.
37. 37 Steinmetz A, Hocke G, Saile R, Puchois P, Fruchart JC: Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim Biophys Acta 1989, 1006:173-178.
38. 38 Kisilevsky R, Subrahmanyan L: Serum amyloid A changes high density lipoprotein's cellular affinity: a clue to serum amyloid's principal function. Lab Invest 1992, 66:778-785.
39. 39 Liang JS, Schreiber BM, Salmona M, Phillip G, Gonnerman WA, de Beer FC, Sipe JD: Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells. J Lipid Res 1996, 37:2109-2116.
40. 40 Baumberger C, Ulevitch R, Dayer J: Modulation of endotoxic activity of lipopolysaccharide by high-density lipoprotein. Pathobiology 1991, 59:378-383.
41. 41 Aldo-Benson MA, Benson MD: SAA suppression of immune response in vitro: evidence for an effect on T cell-macrophage interaction. J Immunol 1982, 128:2390-2392.
42. 42 Peristeris P, Gaspar A, Gros P, Laurent P, Bernon H, Bienvenu J: Effects of serum amyloid A protein on lymphocytes, HeLa, and MRC5 cells in culture. Biochem Cell Biol 1989, 67:365-370.
43. 43 Shainkin-Kestenbaum R, Zimlichman S, Lis M, Lidor C, Pomerantz M, Knyszynski A, et al.: Effect of serum amyloid A, HDL-apolipoprotein on endothelial cell proliferation: implication of an enigmatic protein to atherosclerosis. Biomed Pept Proteins Nucleic Acids 1997, 2:79-84.
44. 44 Zimlichman S, Danon A, Nathan I, Mozes G, Shainkin-Kestenbaum R: Serum amyloid A, an acute phase protein, inhibits platelet activation. J Lab Clin Med 1990, 116:180-186.
45. 45 Linke RP, Bock V, Valet G, Rothe G: Inhibition of the oxidative burst response of N formyl peptide-stimulated neutrophils by serum amyloid A protein. Biochem Biophys Res Commun 1991, 176:1100-1105.
46. 46 Gatt ME, Urieli-Shoval S, Preciado-Patt L, Fridkin M, Calco S, Azar Y, Matzner Y: Effect of serum amyloid A on selected in vitro functions of isolated human neutrophils. J Lab Clin Med 1998, 132:414-420.
47. 47 Preciado PL, Levartowsky D, Pras M, Hershkoviz R, Lider O, Fridkin M: Inhibition of cell adhesion to glycoproteins of the extracellular matrix by peptides corresponding to serum amyloid A: toward understanding the physiological role of an enigmatic protein. Eur J Biochem 1994, 223:35-42.
48. 48 Xu L, Badolato R, Murphy WJ, Longo DL, Anver M, Hale S, et al.: A novel biologic function of serum amyloid A: induction of T lymphocyte migration and adhesion. J Immunol 1995, 155:1184-1190.
49. 49 Preciado-Patt L, Hershkoviz R, Fridkin M, Lider O: Serum amyloid A binds specific extracellular matrix glycoproteins and induces the adhesion of resting CD4+ T cells. J Immunol 1996, 156:1189-1895.
50. 50 Hershkoviz R, Preciado-Patt L, Lider O, Fridkin M, Dastych J, Metcalfe DD, Mekori YA: Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion. Am J Physiol 1997, 273:179-187.
51. 2-microglobulin-like proteins. Science 1989, 243:655-657.
52. 52 Migita K, Kawabe Y, Tominaga M, Origuchi T, Aoyagi T, Eguchi K: Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab Invest 1998, 78:535-539.
53. 53 Mitchell TI, Jeffrey JJ, Palmiter RD, Brinckerhoff CE: The acute phase reactant serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases collagenase and stromelysin. Biochim Biophys Acta 1993, 1156:245-254.
54. 54 Shainkin-Kestenbaum R, Zimlichman S, Lis M, Preciado-Patt L, Fridkin M, Berenheim J: Modulation of prostaglandin I2 production from bovine aortic endothelial cells by serum amyloid A and its N-terminal tetradecapeptide. Biomed Pept Proteins Nucleic Acids 1997, 2:101-106.
55. 55 Turnell W, Sarra R, Glover ID, Baum JO, Caspi D, Baltz ML, Pepys MB: Secondary structure prediction of human SAA1: presumptive identification of calcium and lipid binding sites. Mol Biol Med 1986 3:387-407.
56. 56 Patel H, Bramall J, Waters H, De Beer MC, Woo P: Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis. Biochem J 1996, 318:1041-1049.
57. 57 Ancsin JB, Kisilevsky R: Characterization of high affinity binding between laminin and the acute-phase protein, serum amyloid A. J Biol Chem 1997, 272:406-413.
58. 58 Ancsin JB, Kisilevsky R: Laminin interactions with the apoproteins of acute-phase HDL: preliminary mapping of the laminin binding site on serum amyloid A. Amyloid:lnt J Exp Clin Invest 1999, 6:37-47.
59. 59 Ancsin JB, Kisilevsky R: The heparin/heparan sulfate-binding site on aposerum amyloid A: implications for the therapeutic intervention of amyloidosis. J Biol Chem 1999, 274:7172-7181. A heparin/heparan sulfate binding site was found on SAA and was implicated in the pathogenesis of AA amyloidosis. This site mediates binding of many proteins to heparan-sulfate-proteoglycans found in the extracellular matrices of human tissues and is implicated in many physiologic and pathologic processes involving cell attachment, migration, proliferation, and differentiation. The significance of this site in SAA, beyond its possible role in AA amyloidosis, requires further investigation.
60. 60 Kluve-Beckerman B, Liepnieks JJ, Wang L, Benson MD: A cell culture system for the study of amyloid pathogenesis: amyloid formation by peritoneal macrophages cultured with recombinant serum amyloid A. Am J Pathol 1999, 155:123-133.
61. 61 Solomon A, Weiss DT, Schell M, Hrncic R, Murphy CL, Wall J, et al.: Transgenic mouse model of AA amyloidosis. Am J Pathol 1999, 154:1267-1272.
62. 62 Orpiszewski J, Benson MD: Induction of β-sheet structure in amyloidogenic peptides by neutralization of aspartate: a model for amyloid nucleation. J Mol Biol 1999, 289:413-428.
63. 63 Coetzee GA, Strachan AF, van-der-Westhuyzen DR, Hoppe HC, Jeenah MS, de-Beer FC: Serum amyloid A-containing human high density lipoprotein 3: density, size and apolipoprotein composition. J Biol Chem 1986, 261:9644-9651.
64. 64 Kumon Y, Loose LD, Birbara CA, Sipe JD: Rheumatoid arthritis exhibits reduced acute phase and enhanced constitutive serum amyloid A protein in synovial fluid relative to serum: a comparison with C-reactive protein. J Rheumatol 1997, 24:14-19.
65. 65 McNiff PA, Stewart C, Sullivan J, Showell HJ, Gabel CA: Synovial fluid from rheumatoid arthritis patients contains sufficient levels of IL-1 beta and IL-6 to promote production of serum amyloid A by Hep3B cells. Cytokine 1995, 7:209-219.
66. 66 Rosenthal CJ, Sullivan LE: Serum amyloid A to monitor cancer dissemination. Ann Intern Med 1979, 91:383-390.
67. 67 Biran H, Friedman N, Neumann L, Pras M, Shainkin-Kestenbaum R: Serum amyloid A (SAA) variations in patients with cancer: correlation with disease activity, stage, primary site, and prognosis. J Clin Pathol 1986, 39:794-797.
68. 68 Ruoslahti E, Pierschbacher MD: New perspectives in cell adhesion: RGD and integrins. Science 1987, 238:491-496.
69. 69 Nicosia RF, Bonanno E: Inhibition of angiogenesis in vitro by Arg-Gly-Asp-containing synthetic peptide. Am J Pathol 1991, 138:829-833.
70. 70 Iwamoto Y, Nomizu M, Yamada Y, Ito Y, Tanaka K, Sugioka Y: Inhibition of angiogenesis, tumor growth and experimental metastasis of human fibrosarcoma cells HT1080 by a multimeric form of the laminin sequence Tyr-lle-Gly-Ser-Arg (YIGSR). Br J Cancer 1996, 73:589-595.
71. 71 Yamada T: Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness. Clin Chem Lab Med 1999, 37:381-388.